Book Chapter
Frazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 91-104) edited by R. W. Tindle. Austin, USA: R.G. Landes Company.
Journal Articles
Herd, K. A., Nelson, M., Mahalingam, S. and Tindle, R. W. (2010). Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.. Journal of General Virology, 91 (5), 1302-1310. doi: 10.1099/vir.0.015396-0
Herd, K. A., Nissen, M. D., Hopkins, P. M., Sloots, T. P. and Tindle, R. W. (2008). Major histocompatibility complex class I cytotoxic T lymphocyte immunity to human metapneumovirus (hMPV) in individuals with previous hMPV infection and respiratory disease. The Journal of Infectious Diseases, 197 (4), 584-592. doi: 10.1086/526536
Haigh, Oscar, Guo, Huayang, Edgtton, Kristy, Mather, Michael, Herd, Karen A. and Tindle, Robert W. (2007). Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg)vaccine enhance CTL responses, but not tumor protection. Virology, 368 (2), 363-375. doi: 10.1016/j.virol.2007.06.041
Herd, Karen A., Wiethe, Carsten and Tindle, Robert W. (2007). Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine. Vaccine, 25 (28), 5209-5219. doi: 10.1016/j.vaccine.2007.04.083
Woo, Wai-Ping, Doan, Tracy, Herd, Karen A., Netter, Hans-Jurgen and Tindle, Robert W. (2006). Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. Journal Of Virology, 80 (8), 3975-3984. doi: 10.1128/JVI.80.8.3975-3984.2006
Herd, Karen A., Mahalingam, Suresh, Mackay, Ian M., Nissen, Michael, Sloots, Theo P. and Tindle, Robert W. (2006). Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. Journal of Virology, 80 (4), 2034-2044. doi: 10.1128/JVI.80.4.2034-2044.2006
Doan, T., Herd, K., Ramshaw, I., Thomson, S. and Tindle, R. W. (2005). A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour. Cancer Immunology Immunotherapy, 54 (2), 157-171. doi: 10.1007/s00262-004-0544-6
Herd, Karen A., Harvey, Tracey, Khromykh, Alexander A. and Tindle, Robert W. (2004). Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology, 319 (2), 237-248. doi: 10.1016/j.virol.2003.10.032
Street, MD, Doan, T, Herd, KA and Tindle, RW (2002). Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology, 106 (4), 526-536. doi: 10.1046/j.1365-2567.2002.01442.x
Tindle, Robert W., Herd, Karen A., Doan, Tracy, Bryson, Greg, Leggatt, Graham R., Lambert, Paul, Ian H. Frazer, and Street, Michael D. (2001). Nonspecific down-regulation of CD8+ T-Cell responses in mice expressing human Papillomavirus Type 16 E7 oncoprotein from the keratin-14 promoter. Journal of Virology, 75 (13), 5985-5997. doi: 10.1128/JVI.75.13.5985-5997.2001
Azoury-Ziadeh, R, Herd, K, Fernando, GJP, Lambert, P, Frazer, IH and Tindle, RW (2001). Low level expression of human papillomavirus type 16 (HPV16) E6 in squamous epithelium does not elicit E6 specific B- or T-helper immunological responses, or influence the outcome of immunisation with E6 protein. Virus Research, 73 (2), 189-199. doi: 10.1016/S0168-1702(00)00241-0
Doan, Tracy, Herd, Karen A., Lambert, Paul F., Fernando, Germain J. P., Street, Michael D. and Tindle, Robert W. (2000). Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization. Cancer Research, 60 (11), 2810-2815.
Street, M., Herd, K., Londono, P., Doan, T., Dougan, G., Kast, W. M. and Tindle, R. W. (1999). Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region. Archives of Virology, 144 (7), 1323-1343. doi: 10.1007/s007050050590
Doan, Tracy, Herd, Karen, Street, Michael, Bryson, Gregory, Fernando, Germain, Lambert, Paul and Tindle, Robert (1999). Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. Journal of Virology, 73 (7), 6166-6170. doi: 10.1128/jvi.73.7.6166-6170.1999
Azoury-Ziadeh, Rania, Herd, Karen, Fernando, Germain J. P., Frazer, Ian H. and Tindle, Robert W. (1999). T-Helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16. Viral Immunology, 12 (4), 297-312. doi: 10.1089/vim.1999.12.297
Doan, Tracy, Chambers, Melita, Street, Michael, Fernando, Germain J. P., Herd, Karen, Lambert, Paul and Tindle, Robert (1998). Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology, 244 (2), 352-364. doi: 10.1006/viro.1998.9128
Herd, K., Fernando, G. J. P., Dunn, L. A., Frazer, I. H., Lambert, P. and Tindle, R. W. (1997). E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein. Virology, 231 (1), 155-165. doi: 10.1006/viro.1997.8491
Londono, L. Patricia, Chatfield, Steven, Tindle, Robert W., Herd, Karen, Gao, Xiao-Ming, Frazer, Ian and Dougan, Gordon (1996). Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine, 14 (6), 545-552. doi: 10.1016/0264-410X(95)00216-N
Tindle, R. W., Croft, S., Herd, K., Malcolm, K., Geczy, A. F., Stewart, T. and Fernando, G. J. (1995). A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clinical and Experimental Immunology, 101 (2), 265-271. doi: 10.1111/j.1365-2249.1995.tb08349.x
Tindle, Robert W., Herd, Karen, Londoño, Patricia, Fernando, Germain J. P., Chatfield, Steven N., Malcolm, Karen and Dougan, Gordon (1994). Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice. Virology, 200 (2), 547-557. doi: 10.1006/viro.1994.1217
Tindle, Robert W., Murray, Barbara, Herd, Karen, Kennedy, Lynn, O'Connor, Dan T., Fernando, Germain J. P. and Frazer, Ian H. (1992). Humoral immune response to the E7 open reading frame protein of human papillomavirus genotype 16 in subjects with anogenital papillomavirus infection and controls. Immunology and Infections Diseases, 2, 223-228.
Conference Paper
Tindle, R., Londono, P., Herd, K., Frazer, I. and Dougan, G. (1993). Use of Recombinant Hepatitis-B Core Antigen Particles to Deliver Hpv16-E7 Immunogenic Signals. -, -, -. Oxford, United Kingdom: John Wiley & Sons.